Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Needle-Free Drug Delivery Devices Market Size?
The market for needle-free drug delivery systems has experienced a boom in recent years, with predictions indicating growth from $16.7 billion in 2024 to $18.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.0%. Factors leading to this impressive growth in the historic period include a surge in chronic diseases, heightened demand for pain-free drug administration, an aging population, focus on patient adherence and safety, governing body support for needleless technologies, and the flourishing pharmaceutical industry.
The market for needle-free drug delivery devices is anticipated to experience a rapid expansion in the coming years, expecting to attain $27.68 billion by 2029 with a compound annual growth rate (CAGR) of 10.5%. This anticipated expansion during the forecast period can be linked to the growing requirement for pain-free drug administration, increased focus on healthcare solutions oriented around the patient, widening applications for children and the elderly, a surge in chronic diseases requiring regular injections, advancements in technology that boost device efficiency and ease of use, expanded healthcare access in developing markets, and a rise in investment towards R&D for innovative delivery systems. Key trends for the forecast period encompass higher uptake of wearable and connected devices, the advent of innovative microfluidic technologies, escalating focus on needle-free solutions suitable for children, the incorporation of artificial intelligence and machine learning, and broader applications in home healthcare environments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
Which Factors Are Steering Growth In The Needle-Free Drug Delivery Devices Market?
The expected surge in the needle-free drug delivery device market is largely due to the increasing rates of diabetes. This chronic health problem, defined by elevated blood sugar levels, stems from either improper insulin production or the body’s inefficient use of insulin. Factors such as sedentary lifestyles, poor diets, genetics, urbanization, and aged populations, coupled with limited healthcare access and global increases in obesity, contribute to the increasing diabetes numbers. Needle-free drug delivery devices offer a preferable alternative to standard insulin injections, utilizing technologies like jet injectors or transdermal patches that administer insulin through the skin, bypassing the need for needles. This method reduces the discomfort and fear associated with injections, resulting in increased patient comfort. For instance, the National Health Service reported in June 2024 that in 2023, the NHS identified an additional 549,000 individuals in England in danger of developing type 2 diabetes. This brings the total count of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330—an almost 20% increase from the 3,065,825 recorded in 2022. Consequently, the escalating rates of diabetes are fueling the accelerated growth of the needle-free drug delivery device market.
How Is The Needle-Free Drug Delivery Devices Market Organized By Different Segments?
The needle-free drug delivery devicesmarket covered in this report is segmented –
1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
3) By End-User: Hospitals And Clinics; Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi); Metered Dose Inhalers (Mdi); Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors; Spring-Powered Jet Injectors; Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays; Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches; Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices; Implantable Drug Delivery Systems; Sublingual Drug Delivery Devices
What Current And Upcoming Trends Are Shaping The Needle-Free Drug Delivery Devices Market?
Leading firms within the needle-free drug delivery device market are prioritizing progressive solutions, such as dual chamber inhalers, to improve effectiveness and ease of use, satisfying the evolving demands of patients and medical professionals. A dual-chamber inhaler is an apparatus with two discrete sections that can contain different medications. This configuration enables the fusion of multiple drugs in a single inhaler, consolidating treatment, and enhancing patient convenience. For example, in April 2024, Berry Global, a plastic manufacturing company from the US, launched the BerryHaler, an innovative dry powder inhaler (DPI) intended to transform patient-focused healthcare solutions. This dual-chamber inhaler possesses a dose counter, which guarantees accurate medication administration. Its entirely plastic build, free of any metallic components, renders it perfect for sophisticated inhalation therapies, simplifying dosage, and merging multiple medicines effectively. The augmented features consist of a two-way mouthpiece cover for comfort and cleanliness, and audible signals to demonstrate correct usage. The built-in dose counter supports precise monitoring of medication usage, deterring dosage mistakes.
Who Are The Most Influential Companies In The Needle-Free Drug Delivery Devices Market?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG
Access The Complete Report Here:
Which Region Dominates The Needle-Free Drug Delivery Devices Market Today?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp
Browse Through More Reports Similar to the Global Needle-Free Drug Delivery Devices Market 2025, By The Business Research Company
Microneedle Drug Delivery Systems Global Market Report 2025
Hypodermic Syringes And Needles Global Market Report 2025
Injectable Drug Delivery Devices Market 2025
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
